Article
Immunological and clinical markers of post-acute sequelae of COVID-19: Insights from mild and severe cases six months post-infection
2025-02-21
Abstract excerpt
<h4>SUMMARY</h4> Post-acute sequelae of COVID-19 (PASC) is a complex and multifaceted clinical challenge requiring to emphasize its underlying pathophysiological mechanisms. This study assessed hundreds of virological, serological, immunological, and tissue damage biomarkers in two patient cohorts who experienced mild (n=270) or severe (n=188) COVID-19, 6 to 9 months post-initial infection, and in which 40% and 5...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 923d3438-b225-52be-aa4e-6a551035d23c
- DOI
- 10.1101/2025.02.18.638851
